SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-091806
Filing Date
2021-03-24
Accepted
2021-03-24 06:08:04
Documents
13
Period of Report
2021-03-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d113288d8k.htm   iXBRL 8-K 27921
  Complete submission text file 0001193125-21-091806.txt   187798

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA tmb-20210322.xsd EX-101.SCH 4143
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tmb-20210322_def.xml EX-101.DEF 13843
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE tmb-20210322_lab.xml EX-101.LAB 22833
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tmb-20210322_pre.xml EX-101.PRE 14811
6 EXTRACTED XBRL INSTANCE DOCUMENT d113288d8k_htm.xml XML 5431
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Filer) CIK: 0000791908 (see all company filings)

IRS No.: 522154066 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39801 | Film No.: 21766499
SIC: 2834 Pharmaceutical Preparations